Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday June 4, 2026, at 2:00 PM ET, Aclaris' Chief Executive Officer Dr. Neal Walker and other members of Aclaris' senior leadership team will participate in a fireside chat during the 2026 Jefferies Global Healthcare Conference in New York, NY.

A live and archived webcast of this event will be accessible on the Events page of the Aclaris website, www.aclaristx.com. The webcast will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

ACRS
The Conversation (0)
Skyharbour Resources Engages Connect 4 Marketing for Digital Investor Awareness Campaign

Skyharbour Resources Engages Connect 4 Marketing for Digital Investor Awareness Campaign

Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) ("Skyharbour" or the "Company") has engaged Connect 4 Marketing Ltd. ("Connect 4") to provide digital marketing services designed to increase investor awareness of the Company over a 12-month term. The Company has entered... Keep Reading...
Standard Uranium Closes Final Tranche of LIFE Offering

Standard Uranium Closes Final Tranche of LIFE Offering

Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce that it has closed the final tranche of its non-brokered private placement (the "Offering") being conducted in reliance upon the listed issuer financing exemption under Part... Keep Reading...
America May Be Sitting on a Gold and Silver Fortune Hiding in Plain Sight

America May Be Sitting on a Gold and Silver Fortune Hiding in Plain Sight

MiningNewsWire Editorial Coverage: With U.S. debt climbing above 100% of GDP while central banks are still accumulating gold, investors are once again seeking safety in silver and gold. Zinc, lead, copper and silver, meanwhile, all now appear on the 2025 List of Critical Minerals published by... Keep Reading...
Standard Uranium Confirms Uranium and Rare Earth Element Enrichment in Winter Drilling at the Rocas Project

Standard Uranium Confirms Uranium and Rare Earth Element Enrichment in Winter Drilling at the Rocas Project

Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to report a summary of geochemical assay results from its winter 2026 drill program at the Rocas Uranium Project ("Rocas", or the "Project") located 75 kilometers southwest of the Key... Keep Reading...
Prince Silver Receives Approval for Exploration Access North of Prince Claims and Expands Land Position in Lincoln County

Prince Silver Receives Approval for Exploration Access North of Prince Claims and Expands Land Position in Lincoln County

Prince Silver Corp. (CSE: PRNC) (OTCQX: PRNCF) (FSE: T130) (the "Company" or "Prince Silver") announces that, on November 2, 2026, the Lincoln County Board of Commissioners approved an initial access agreement relating to three contiguous patented mineral claims immediately north of the... Keep Reading...

Interactive Chart

Latest Press Releases

Related News